质粒 DNA 製造市场：按产品类型、等级、应用、製造类型、发展阶段、地区 - 规模、份额、展望、机会分析，2022-2030 年

质粒DNA是一种环状双链DNA，存在于细菌细胞质中，独立于细菌染色体进行复製。 质粒是细胞内的一个小的额外染色体 DNA 分子，它与染色体 DNA 物理分离并能够独立复製。 质粒最常见于细菌中，作为小的、环状的、双链 DNA 分子存在。 然而，质粒也可以存在于古细菌和真核生物中。

每个质粒都有自己的 "复製起点" 。 这是一段由宿主细菌可靠地复製（拷贝）的 DNA。 正因为如此，质粒可以独立于细菌染色体进行自我复製，并且细菌细胞内可以有许多（有时数百个）质粒拷贝。

市场动态

为了满足合适的产品及其产量要求，对现有製造技术进行创新的需求预计将为市场上的主要参与者提供巨大的增长机会。 例如，2021 年 3 月，总部位于盖恩斯维尔的生物技术公司 Evolugate, LLC 证明其专有技术可用于提高质粒 DNA 製造的吞吐量。

预计市场参与者通过收购来扩大其产品组合等无机策略将推动预测期内的市场增长。 例如，2022 年 1 月，Aldebron 宣布收购 Nature Technology Corporation (NTC)，后者是一家开髮用于细胞和基因治疗领域的创新和专有质粒构建体和製造解决方案的公司。 NTC 基于核酸的技术包括 Nanoplasmid，这是一种专有的载体结构，可提高质粒和生物製剂的安全性和性能。

这项研究的主要特点

• 本报告对全球质粒 DNA 製造市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%) 增长情况。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供重要的见解，例如市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
• 它根据以下参数介绍了全球质粒 DNA 製造市场的主要参与者 - 公司亮点、产品组合、主要亮点、财务业绩、作为本研究的一部分涵盖的关键战略公司包括 Cobra Biologics 和 Pharmaceutical Services（Charles River Laboratories)、VGXI, Inc.、Aldevron (Danaher)、Kaneka Corporation、Nature Technology、PlasmidFactory GmbH & Co. KG、Cell and Gene Therapy Catapult、LakePharma, Inc.、MeiraGTx Limited、Eurofins Genomics、Vigene Biosciences、Luminous BioSciences ( LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc.、Altogen Biosystems、Puresyn, Inc.、Cepham Life Sciences、Catalent, Inc.、Biomiga、Waisman Biomanufacturing
• 这份报告中的见解应该能够让企业营销人员和管理人员就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。.
• 《全球质粒 DNA 製造市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球质粒 DNA 製造市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 市场概况：按等级
  • 市场概况：按应用分类
  • 按製造类型分类的快照
  • 市场概况：按发展阶段
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场吸引力分析
  • 市场机会
• 产品发布
• 合併、收购、联合研究
• 监管准则和合规性
• 主要发展状况
• 害虫分析
• 技术
• 对 PORTER 的分析
• 定价分析 (2021)
• 针对质粒 DNA 疫苗开发的指南
• 基因组效价

第 4 章全球质粒 DNA 製造市场-冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• COVID-19 的流行病学特征
• 对供需的影响

第 5 章按产品类型分列的全球质粒 DNA 製造市场，2017-2030

• 病毒载体
• 质粒DNA
• 非病毒式

第 6 章按等级分列的全球质粒 DNA 製造市场，2017-2030

• GMP 等级
• 研发级别
• 临床等级

第 7 章质粒 DNA 製造的全球市场，按应用，2017-2030（百万美元

• DNA疫苗
• 基因治疗
• 免疫疗法
• RNA 疫苗
• 其他

第 8 章质粒 DNA 製造全球市场，按製造类型，2017-2030（百万美元

• 外包
• 内部製造

第 9 章全球质粒 DNA 製造市场，按发展阶段，2017-2030，（百万美元）

• 临床前药物
• 临床药物
• 已上市药物

第 10 章全球质粒 DNA 製造市场，按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第11章竞争格局

• Cobra Biologics and Pharmaceutical Services（Charles River Laboratories）.
• VGXI, Inc.
• Aldevron（Danaher）
• Kaneka Corporation
• Nature Technology
• PlasmidFactory GmbH & Co. KG
• Cell and Gene Therapy Catapult
• LakePharma, Inc.
• MeiraGTx Limited
• Eurofins Genomics
• Vigene Biosciences
• Luminous BioSciences（LBS）, LLC
• GenScript
• GENEWIZ
• Creative Biogene
• Akron Biotech
• Biomay
• JAFRAL Ltd.
• WuXi Biologics
• GeneImmune Biotechnology Corp.
• Lonza
• Greenpak Biotech Ltd.
• Luina Bio（AcuraBio）
• Ajinomoto Bio-Pharma
• Synbio Technologies
• Genopis Inc.
• Altogen Biosystems
• Puresyn, Inc.
• Cepham Life Sciences
• Catalent, Inc.
• Biomiga
• Waisman Biomanufacturing

第12章章节

• 调查方法
• 关于出版商

Circular double-stranded DNA present in the cytoplasm of a bacteria that replicate independently from the bacterial chromosome is called a plasmid DNA. Plasmids are small extra chromosomal DNA molecules within cells that are physically separated from the chromosomal DNA and capable of independent replication. They are most commonly found as small circular double-stranded DNA molecules in bacteria. However, plasmids can be present in archaea and eukaryotes.

Each plasmid has its own "origin of replication". This is a stretch of DNA that ensures it is replicated (copied) by the host bacteria. Because of this, plasmids can copy themselves independently of the bacterial chromosome, and there can be many, possibly hundreds, copies of the plasmid within the bacterial cell.

Market Dynamics

Demand for innovation in existing manufacturing technologies, in order to meet the requirement of appropriate products and its volume is expected to provide immense growth opportunities for key players in the market. For instance, in March 2021, Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.

The increasing inorganic strategies such as acquisition by the key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, In January 2022, Aldevron announced the acquisition of Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC's nucleic acid-based technologies include Nanoplasmid, a proprietary vector construct that improves the safety and performance of plasmids and biologics.

Key features of the study:

• This report provides in-depth analysis of the global plasmid DNA manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global plasmid DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global plasmid DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasmid DNA manufacturing market

Detailed Segmentation:

• Global Plasmid DNA Manufacturing Market, By Product Type:
  • Viral Vectors
    • Retroviral
    • Adenoviral
    • Lentiviral
    • Adeno Associates
    • Others
  • Plasmid DNA
    • mRNA
    • Others
  • Non-viral
    • Lipid/Polymer
    • Electroporation
    • Nanoparticles
    • Others
• Global Plasmid DNA Manufacturing Market, By Grade:
  • GMP Grade
  • R&D Grade
  • Clinical Grade
• Global Plasmid DNA Manufacturing Market By Application:
  • DNA Vaccines
  • Gene Therapy
  • Immunotherapy
  • RNA Vaccines
  • Others
• Global Plasmid DNA Manufacturing Market By Manufacturing Type:
  • Outsourcing
  • In-house Manufacturing
• Global Plasmid DNA Manufacturing Market By Development Phase:
  • Pre-Clinical Therapeutics
  • Clinical Therapeutics
  • Marketed Therapeutics
• Global Plasmid DNA Manufacturing Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • India
  • China
  • Japan
  • Australia
  • ASEAN
  • South Korea
  • Rest of Middle East
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Japan
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Cobra Biologics and Pharmaceutical Services (Charles River Laboratories)*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • VGXI, Inc.
  • Aldevron (Danaher)
  • Kaneka Corporation
  • Nature Technology
  • PlasmidFactory GmbH & Co. KG
  • Cell and Gene Therapy Catapult
  • LakePharma, Inc.
  • MeiraGTx Limited
  • Eurofins Genomics
  • Vigene Biosciences
  • Luminous BioSciences (LBS), LLC
  • GenScript
  • GENEWIZ
  • Creative Biogene
  • Akron Biotech
  • Biomay
  • JAFRAL Ltd.
  • WuXi Biologics
  • GeneImmune Biotechnology Corp.
  • Lonza
  • Greenpak Biotech Ltd.
  • Luina Bio (AcuraBio)
  • Ajinomoto Bio-Pharma,
  • Synbio Technologies, Genopis Inc.
  • Altogen Biosystems, Puresyn, Inc.
  • Cepham Life Sciences, Catalent, Inc.
  • Biomiga
  • Waisman Biomanufacturing

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Grade
  • Market Snapshot, By Application
  • Market Snapshot, By Manufacturing Type
  • Market Snapshot, By Development Phase
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2021)
• Guidelines Specific for the Development of Plasmid DNA Vaccines
• Genomic Titer

4. Global Plasmid DNA Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Plasmid DNA Manufacturing Market, By Product Type, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Viral Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retroviral
  • Adenoviral
  • Lentiviral
  • Adeno Associates
  • Others
• Plasmid DNA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • mRNA
  • Others
• Non-viral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Lipid/Polymer
  • Electroporation
  • Nanoparticles
  • Others

6. Global Plasmid DNA Manufacturing Market, By Grade, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• GMP Grade
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• R&D Grade
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clinical Grade
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Plasmid DNA Manufacturing Market, By Application, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• DNA Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• RNA Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Plasmid DNA Manufacturing Market, By Manufacturing Type, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Outsourcing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• In-house Manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Plasmid DNA Manufacturing Market, By Development Phase, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Pre-Clinical Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clinical Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Marketed Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Plasmid DNA Manufacturing Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Grade, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2017 - 2030, (US$ Million
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Cobra Biologics and Pharmaceutical Services (Charles River Laboratories).*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• VGXI, Inc.
• Aldevron (Danaher)
• Kaneka Corporation
• Nature Technology
• PlasmidFactory GmbH & Co. KG
• Cell and Gene Therapy Catapult
• LakePharma, Inc.
• MeiraGTx Limited
• Eurofins Genomics
• Vigene Biosciences
• Luminous BioSciences (LBS), LLC
• GenScript
• GENEWIZ
• Creative Biogene
• Akron Biotech
• Biomay
• JAFRAL Ltd.
• WuXi Biologics
• GeneImmune Biotechnology Corp.
• Lonza
• Greenpak Biotech Ltd.
• Luina Bio (AcuraBio)
• Ajinomoto Bio-Pharma
• Synbio Technologies
• Genopis Inc.
• Altogen Biosystems
• Puresyn, Inc.
• Cepham Life Sciences
• Catalent, Inc.
• Biomiga
• Waisman Biomanufacturing

12. Section

• Research Methodology
• About Us